You are here
NICE ACD- imatinib intolerance
NICE - new ACD for imatinib intolerantce:
www.nice.org.uk/guidance/index.jsp?action=article&o=47297
nice.org.uk/guidance/index.jsp?action=article&o=47297">www.nice.org.uk/guidance/index.jsp?action=article&o=47297
The do not recommend dasatinib or nilotinib for use in IM intolerant patients.
The deadline for both official and individual responses to this new ACD is March 2nd. The following FAD meeting will take place on March 9th at NICE headquarters in Manchester.
NICE press statement: